Braveheart Bio, Inc. (BRVE) stock
Close on Nov 12, 2026Market cap $1.85BP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Sep 30, 2026
Valuation
- Market cap
- $1.85B
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 3.71
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Book value per share
- $9.55
- Diluted shares
- 52M
Trading
- Previous close
- $20.90
- Open
- $20.97
- Day's range
- $20.01 – $21.30
- Volume
- 256,071
- Average volume (20 days)
- 400,112
- RSI (14 days)
- 50.4
- Relative volume
- 0.99×
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | BRVE | S&P 500 | Difference | BRVE per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +0.7% | -2.7% | +3.4 pts | ||
| 3 months | -21.6% | -1.7% | −19.9 pts |
Two years at a glance
Fiscal years 2024 to 2025, USD
Press releases
Releases Braveheart Bio filed with the SEC as exhibits to Form 8-K or 6-K
Braveheart Bio stock: common questions
What is Braveheart Bio's stock price?
BRVE closed at $20.50 on Nov 12, 2026, down 1.91% on the day.
What is Braveheart Bio's market cap?
Braveheart Bio was worth $1.85B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
Does Braveheart Bio pay a dividend?
No. Braveheart Bio has not paid a cash dividend over the last twelve months.
How many BRVE shares are sold short?
5M shares were sold short at the latest FINRA report, 28.92% of the float, or 19.6 days of average trading volume.
Who are Braveheart Bio's competitors?
Companies most similar to Braveheart Bio by business, industry and size include LLY, JNJ, ABBV, MRK, AZN.
See a number that looks wrong?